Director Daniel B. Soland resigns from Acadia board and governance committee chair

ACADIA PHARMACEUTICALS INC

Resignation effective October 30, 2025.
Mr. Soland stepped down from the Board and as Chair of Nominating and Corporate Governance Committee.
Resignation not due to any dispute or disagreement with the Company or Board.
No replacement for the Board seat or committee chair has been announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.